MREO

Mereo BioPharma Group plc - ADR

0.35

USD

MREO Earnings Reports

Positive Surprise Ratio

MREO beat 2 of 7 last estimates.

29%

Next Report

Date of Next Report

May 11, 2026

Estimate for Q1 26 (Revenue/ EPS)

$7.14M

-$0.01

Implied change from Q4 25 (Revenue/ EPS)

Implied change from Q1 25 (Revenue/ EPS)

-90.00%

Mereo BioPharma Group plc - ADR earnings per share and revenue

On Mar 19, 2026, MREO reported earnings of -0.01 USD per share (EPS) for Q4 25, beating the estimate of -0.01 USD, resulting in a 23.66% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.56% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 8 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 7.14 million USD, implying an increase of 0.00% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Precigen, Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.01

Surprise

+88.24%

Absci Corporation Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.23

Surprise

-16.04%

Candel Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.25

Actual

-$0.54

Surprise

-115.31%

LENZ Therapeutics, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.99

Actual

-$1.15

Surprise

-17.10%

Fennec Pharmaceuticals Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

$0.03

Actual

-$0.11

Surprise

-408.12%

Equillium, Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.04

Surprise

+35.28%

MaxCyte, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.06

Surprise

+26.47%

Celcuity Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$1.06

Actual

-$0.97

Surprise

+8.72%

Dyadic International, Inc.

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.04

Actual

-$0.06

Surprise

-30.72%

TELA Bio, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.18

Actual

-$0.16

Surprise

+14.12%

FAQ

What were Mereo BioPharma Group plc - ADR's earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Mereo BioPharma Group plc - ADR reported EPS of -$0.01, beating estimates by 23.66%, and revenue of $0.00, 0% as expectations.

How did the market react to Mereo BioPharma Group plc - ADR's Q4 2025 earnings?

The stock price moved up 2.56%, changed from $0.35 before the earnings release to $0.36 the day after.

When is Mereo BioPharma Group plc - ADR expected to report next?

The next earning report is scheduled for May 11, 2026.

What are the forecasts for Mereo BioPharma Group plc - ADR's next earnings report?

Based on 8 analysts, Mereo BioPharma Group plc - ADR is expected to report EPS of -$0.01 and revenue of $7.14M for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.